The ESMO Asia Congress, to be held 18-21 December 2015, will comprise both scientific and educational tracks prepared by an international scientific committee. There will be a strong emphasis on state of the art science, including a call for abstracts, and the current standard of care across all major tumour types.
Interactive sessions will be dedicated to the latest ESMO Clinical Practice Guidelines and there will be opportunities for delegates to interact with experts from the region and also with the international oncology community.
The ESMO Asia Congress has been enthusiastically supported by the most important and influential oncology associations in the region, clearly demonstrating the need for international networking and collaboration.
This exciting first ESMO Asia 2015 Congress will take place in Singapore, which has excellent event facilities and is a convenient travel hub for delegates from most countries.
Join ESMO in Singapore for an unparalleled educational, science and networking opportunities.
Learning objectives
– To elaborate clinical relevance of molecular advances in different cancer types and innovative treatment approaches
– To understand current clinical challenges in vast majority of tumour types and novel treatment strategies for particular tumour subtypes
– To provide an update on translating emerging cancer therapeutics into clinical use
Who should attend
The ESMO Asia programme was created by regional and international oncology experts, and the Congress is the place to be for all medical & clinical oncologists, academic & community practising oncologists, clinical, basic, translational & industry researchers, young oncologists, radiotherapists, oncology surgeons, organ-based specialists and all other medical professionals involved in the diagnosis, treatment and follow-up of patients with different types of cancer.
